Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Vesper

Showing results (91-100 of 112) with videos related to

Pageof 12
Sort By:
Pain and Therapy|July 2, 2024
Durability of Evoked Compound Action Potential (ECAP)-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) in a Real-World European Chronic Pain PopulationHarold Nijhuis, Jan-Willem Kallewaard, Johan van de Minkelis, et al.
The Lancet. Oncology|May 15, 2012
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trialWolfgang Wick, Michael Platten, Christoph Meisner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 5, 2025
Long-Term Outcomes on Pallidal Neurostimulation for Dystonia: A Controlled, Prospective 10-Year Follow-UpPatricia Krause, Philipp Mahlknecht, Inger Marie Skogseid, et al.
Neuroimage. Clinical|June 15, 2023
Neuroimaging-based analysis of DBS outcomes in pediatric dystonia: Insights from the GEPESTIM registryBassam Al-Fatly, Sabina J Giesler, Simon Oxenford, et al.
The European Journal of Neuroscience|March 18, 2009
Gamma activity and reactivity in human thalamic local field potentialsFlorian Kempf, Christof Brücke, Farid Salih, et al.
Journal of Clinical Medicine|September 28, 2021
Real-World Outcomes Using a Spinal Cord Stimulation Device Capable of Combination Therapy for Chronic Pain: A European, Multicenter ExperienceJan Willem Kallewaard, Jose Francisco Paz-Solis, Pasquale De Negri, et al.
Neuromodulation : Journal of the International Neuromodulation Society|January 3, 2017
The Polyanalgesic Consensus Conference (PACC): Recommendations for Intrathecal Drug Delivery: Guidance for Improving Safety and Mitigating RisksTimothy R Deer, Jason E Pope, Salim M Hayek, et al.
The Lancet. Neurology|November 6, 2012
Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trialJens Volkmann, Alexander Wolters, Andreas Kupsch, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 2, 2007
Pallidal deep brain stimulation improves quality of life in segmental and generalized dystonia: results from a prospective, randomized sham-controlled trialJoerg Mueller, Inger M Skogseid, Reiner Benecke, et al.
The New England Journal of Medicine|November 10, 2006
Pallidal deep-brain stimulation in primary generalized or segmental dystoniaAndreas Kupsch, Reiner Benecke, Jörg Müller, et al.
Pageof 12

Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
Pain and Therapy|July 2, 2024
Durability of Evoked Compound Action Potential (ECAP)-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) in a Real-World European Chronic Pain PopulationHarold Nijhuis, Jan-Willem Kallewaard, Johan van de Minkelis, et al.
The Lancet. Oncology|May 15, 2012
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trialWolfgang Wick, Michael Platten, Christoph Meisner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 5, 2025
Long-Term Outcomes on Pallidal Neurostimulation for Dystonia: A Controlled, Prospective 10-Year Follow-UpPatricia Krause, Philipp Mahlknecht, Inger Marie Skogseid, et al.
Neuroimage. Clinical|June 15, 2023
Neuroimaging-based analysis of DBS outcomes in pediatric dystonia: Insights from the GEPESTIM registryBassam Al-Fatly, Sabina J Giesler, Simon Oxenford, et al.
The European Journal of Neuroscience|March 18, 2009
Gamma activity and reactivity in human thalamic local field potentialsFlorian Kempf, Christof Brücke, Farid Salih, et al.
Journal of Clinical Medicine|September 28, 2021
Real-World Outcomes Using a Spinal Cord Stimulation Device Capable of Combination Therapy for Chronic Pain: A European, Multicenter ExperienceJan Willem Kallewaard, Jose Francisco Paz-Solis, Pasquale De Negri, et al.
Neuromodulation : Journal of the International Neuromodulation Society|January 3, 2017
The Polyanalgesic Consensus Conference (PACC): Recommendations for Intrathecal Drug Delivery: Guidance for Improving Safety and Mitigating RisksTimothy R Deer, Jason E Pope, Salim M Hayek, et al.
The Lancet. Neurology|November 6, 2012
Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trialJens Volkmann, Alexander Wolters, Andreas Kupsch, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 2, 2007
Pallidal deep brain stimulation improves quality of life in segmental and generalized dystonia: results from a prospective, randomized sham-controlled trialJoerg Mueller, Inger M Skogseid, Reiner Benecke, et al.
The New England Journal of Medicine|November 10, 2006
Pallidal deep-brain stimulation in primary generalized or segmental dystoniaAndreas Kupsch, Reiner Benecke, Jörg Müller, et al.
Pageof 12